These data suggested that nuclear YB-1 may drive HCC cells to obtain stem cell-like properties, thereby maintaining the number of HCC initiating cells and increasing chemoresistance and invasive capacity. The gene discussed is YBX1; the disease is hepatocellular carcinoma.